Jul 162025 CTLA-4: Challenges, Limitations, and Future Perspective in Cancer Immunotherapy Antibody-based cancer immunotherapy has become a powerful asset in the arsenal against malignancies. In this regard, bispecific antibodies (BsAbs) are a grou…
